Is Kelly CRISPR & Gene Editing Technology ETF halal to invest in?

As of September 2026, Kelly CRISPR & Gene Editing Technology ETF XDNA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Kelly CRISPR & Gene Editing Technology ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Kelly CRISPR & Gene Editing Technology ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Kelly CRISPR & Gene Editing Technology ETF updated?

The Shariah compliance status of Kelly CRISPR & Gene Editing Technology ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Kelly CRISPR & Gene Editing Technology ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Kelly CRISPR & Gene Editing Technology ETF?

You can check the latest Shariah compliance status of Kelly CRISPR & Gene Editing Technology ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Kelly CRISPR & Gene Editing Technology ETF XDNA

XDNA Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Kelly CRISPR & Gene Editing Technology ETF is classified as not halal.

NOT HALAL

Is Kelly CRISPR & Gene Editing Technology ETF Halal?

Shariah Compliance Analysis of XDNA ETF

US Equity Health Care

No. As of September 2026, Kelly CRISPR & Gene Editing Technology ETF (XDNA) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Kelly CRISPR & Gene Editing Technology ETF does not pass Musaffa's business and financial screening criteria.

XDNA was created on 2022-01-12 by Kelly. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 2.1m in AUM and 26 holdings. XDNA tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology.

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Chart

Key Statistics of Kelly CRISPR & Gene Editing Technology ETF (XDNA)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
85.15%
Other
14.85%

FAQ's for Kelly CRISPR & Gene Editing Technology ETF (XDNA)

As of September 2026, Kelly CRISPR & Gene Editing Technology ETF XDNA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Kelly CRISPR & Gene Editing Technology ETF using these criteria to determine its compliance status.
The Shariah compliance status of Kelly CRISPR & Gene Editing Technology ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Kelly CRISPR & Gene Editing Technology ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.